Acadian Asset Management’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-308,595
Closed -$611K 1900
2025
Q2
$611K Buy
308,595
+142,825
+86% +$261K ﹤0.01% 1096
2025
Q1
$240K Sell
165,770
-244,487
-60% -$452K ﹤0.01% 1226
2024
Q4
$848K Sell
410,257
-152,652
-27% -$287K ﹤0.01% 952
2024
Q3
$989K Buy
+562,909
New +$1.44M ﹤0.01% 916

Acadian Asset Management's HLVX Position: Q3 2025 in Review

Acadian Asset Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 308,595 shares — an estimated $611K sold.

Acadian Asset Management first reported a position in HLVX in Q3 2024 and held it in 4 quarters. The position peaked at $989K in Q3 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Acadian Asset Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Acadian Asset Management sold 308,595 HilleVax shares in Q3 2025, an estimated $611K.
  • Acadian Asset Management first reported a position in HilleVax in Q3 2024 and held it in 4 quarters.
  • Acadian Asset Management's HilleVax position peaked at $989K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Acadian Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.